Nordic pharmaceutical market growth during the period February–April 2008 was approximately 6% with a similar trend in all Nordic countries.

In the Baltic markets, growth continued at a double digit rate in Estonia but fell significantly below that in Latvia and Lithuania. These markets are characterised by high inflation and a slow down in economic growth. Pharmaceutical consumption and reimbursement are also far below the EU average.